Skip to main content
Safi Shahda, MD, Oncology, Indianapolis, IN, Richard L. Roudebush Veterans Affairs Medical Center

SafiShahdaMD

Oncology Indianapolis, IN

Gastrointestinal Cancer, Hematologic Oncology

Assistant Professor, Medicine, IN Univ Sch of Med

Dr. Shahda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shahda's full profile

Already have an account?

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Indiana University School of Medicine
    Indiana University School of MedicineResidency, Internal Medicine, 2007 - 2010
  • Damascus University Faculty of Medicine
    Damascus University Faculty of MedicineClass of 2004

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 2011 - 2023

Awards, Honors, & Recognition

  • Danny Danielson Inaugural Innovative Translational Award Hoosier Oncology Group

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Phase I Study of EUS-Guided Photodynamic Therapy for Locally Advanced Pancreatic Cancer  
    John M Dewitt, Bert O'Neil, Amikar Sehdev, Safi Shahda, Gastrointestinal Endoscopy
  • Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX  
    Olumide Gbolahan, Amikar Sehdev, Howard H Wu, Safi Shahda, Clinical Cancer Research

Lectures

  • A phase I study of the APE1 protein inhibitor APX3330 in patients with advanced solid tumors. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Prospective trial of preoperative FOLFIRINOX in patients with resectable pancreatic ductal adenocarcinoma (PDAC): Report of early endpoints. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Authored Content

  • Two Months of Therapy: A Case of Pathologic Complete Response to Chemo-Immunotherapy in a Patient with Metastatic Colorectal CancerDecember 2017

Other Languages

  • Arabic

Hospital Affiliations